26. Hypertension Management in Long-Term Survivors

  1. Bipin N Savani MD
  1. Imad Abboud

Published Online: 6 SEP 2013

DOI: 10.1002/9781118473306.ch26

Blood and Marrow Transplantation Long-Term Management: Prevention and Complications

Blood and Marrow Transplantation Long-Term Management: Prevention and Complications

How to Cite

Abboud, I. (2013) Hypertension Management in Long-Term Survivors, in Blood and Marrow Transplantation Long-Term Management: Prevention and Complications (ed B. N. Savani), John Wiley & Sons, Ltd, Oxford, UK. doi: 10.1002/9781118473306.ch26

Editor Information

  1. Professor of Medicine,Director, Long Term Transplant Clinic, Hematology and Stem Cell Transplantation Section, Vanderbilt University Medical Center, Nashville, TN, USA

Author Information

  1. Nephrology Department, Saint Louis Hospital (Assistance Publique – Hôpitaux de Paris), Paris, France

Publication History

  1. Published Online: 6 SEP 2013
  2. Published Print: 1 OCT 2013

ISBN Information

Print ISBN: 9781118473405

Online ISBN: 9781118473306

SEARCH

Keywords:

  • hematopoietic stem cell transplantation;
  • survivors;
  • risk factors;
  • hypertension;
  • blood pressure;
  • incidence;
  • prevalence;
  • follow-up;
  • recommendation;
  • lifestyle

Summary

Hypertension represents a significant health risk for hematopoietic stem cell transplantation survivors. It is defined as persistent systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg if age ≥18 years, and ≥95th percentile for gender, age, and height if age <18 years. Blood pressure should be checked at every clinic visit and at least every year. Laboratory examination helps in stratifying patients who will need more extensive evaluation. Lifestyle intervention should be recommended for all patients. Compelling indications, like heart disease, diabetes, and renal disease, mandate therapy with specific medications; otherwise, any class of antihypertensive agent could be used.